Surgical treatment of primary lung cancer in patients less than 40 years of age
- PMID: 8164051
- DOI: 10.1200/JCO.1994.12.5.981
Surgical treatment of primary lung cancer in patients less than 40 years of age
Abstract
Purpose and methods: The major purpose of this study was to determine whether the survival rate in young lung cancer patients after surgical treatment differs from that in older patients. An analysis was performed for all patients with bronchogenic carcinoma who underwent surgery at Mie University Hospital from 1965 to 1990.
Results: Of 803 patients, 24 (2.99%) were 33 to 39 years old. At the time of surgery, the disease was diagnosed as stage I in seven patients (29%), stage II in four (17%), stage IIIa in seven (29%), stage IIIb in two (8%), and stage IV in four (17%), while 46.3% of the patients older than 40 years of age had either stage IIIa, IIIb, or IV disease. All of the 24 patients less than 40 years of age underwent thoracotomy: curative resection in 14 cases, palliative resection in sex, and probe-thoracotomy in four. The 5-year survival rate for all stages of disease was 31.4% in these 24 patients, and 41.9% in 603 patients greater than 40 years of age. The 5-year survival rate for stage I disease was 35.7% in the seven younger patients and 78.0% in the 207 older patients; for stage II, it was 25.5% in the four younger patients and 40.6% in the 98 older patients; for stage III, it was 33.3% in the nine younger patients and 15.6% in the 250 older patients; and for stage IV, it was 25% in the four younger patients and 6.6% in the 48 older patients. There were no significant differences in survival rate between the two age groups for all patients or for those with each stage of disease.
Conclusion: Although younger patients tended to have more advanced disease, long-term survival in these patients did not differ from that of older patients.
Similar articles
-
Bronchogenic carcinoma in patients younger than 40 years.Ann Thorac Surg. 1983 Nov;36(5):509-15. doi: 10.1016/s0003-4975(10)60678-9. Ann Thorac Surg. 1983. PMID: 6195979
-
Prognosis for resected lung cancer patients with tumors greater than ten centimeters in diameter.Jpn J Clin Oncol. 1990 Dec;20(4):369-73. Jpn J Clin Oncol. 1990. PMID: 2283720
-
Bronchogenic carcinoma in patients age 30 and younger.Ann Thorac Cardiovasc Surg. 2000 Apr;6(2):86-8. Ann Thorac Cardiovasc Surg. 2000. PMID: 10870000
-
Age does not influence early and late tumor-related outcome for bronchogenic carcinoma.Ann Thorac Surg. 2000 Mar;69(3):913-8. doi: 10.1016/s0003-4975(99)01439-3. Ann Thorac Surg. 2000. PMID: 10750783 Review.
-
[Bronchial cancer--development, diagnosis, therapy, prognosis].Wien Klin Wochenschr. 1994;106(14):431-47. Wien Klin Wochenschr. 1994. PMID: 7941590 Review. German.
Cited by
-
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.Front Oncol. 2015 May 26;5:113. doi: 10.3389/fonc.2015.00113. eCollection 2015. Front Oncol. 2015. PMID: 26075181 Free PMC article.
-
Clinicopathological characteristics and prognosis of lung cancer in young patients aged 30 years and younger.J Thorac Dis. 2019 Oct;11(10):4282-4291. doi: 10.21037/jtd.2019.09.60. J Thorac Dis. 2019. PMID: 31737313 Free PMC article.
-
Lung cancer in individuals less than 50 years of age.Lung. 2007 Sep-Oct;185(5):279-286. doi: 10.1007/s00408-007-9021-2. Epub 2007 Aug 20. Lung. 2007. PMID: 17705064
-
Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study.Thorac Cancer. 2024 May;15(15):1218-1227. doi: 10.1111/1759-7714.15300. Epub 2024 Apr 12. Thorac Cancer. 2024. PMID: 38606839 Free PMC article.
-
[Research Progress of Treatment for NSCLC in Young Patients].Zhongguo Fei Ai Za Zhi. 2022 Dec 20;25(12):888-894. doi: 10.3779/j.issn.1009-3419.2022.102.48. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36617475 Free PMC article. Review. Chinese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical